Published peptide research references
Benaglutide
Governed registry record
4 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.
Approved source records
A Health Technology Assessment Based on Chinese Guidelines: Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Type 2 Diabetes Complicated with Cardiovascular Disease.
DOI: 10.2147/tcrm.s375067PMID: 36065167
Source identity and connection checked by Codex (AI).
Cost-effectiveness analysis of four glucagon-like peptide-1 or glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonists for the treatment of adult patients with overweight and obesity in China.
Source identity and connection checked by Codex (AI).
Effect of Benaglutide on Gut Microbiota and Fecal Metabolites in Patients with Type 2 Diabetes Mellitus.
Source identity and connection checked by Codex (AI).
Health Technology Assessment: Evaluation of 7 Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus.
DOI: 10.2147/rmhp.s455897PMID: 38680477
Source identity and connection checked by Codex (AI).
Legacy research context
Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.
Researchers represented
- Han CY
- Ye XM
- Lu JP
- Jin HY
- Wang P
- Xu WW
- Zhang M
- Fu W
- Lin J
- You C
- Zhang J
- Lei J
- Zheng L
- Zheng B
- Liu M
- Liu L
- Li N
- Xie Z
- Li J
- Yang S
- Deng W
- Chen J
- Hu J
- Li M
- Hu X